Therapeutic Advances in Endocrinology and Metabolism

Papers
(The H4-Index of Therapeutic Advances in Endocrinology and Metabolism is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging – a narrative review117
Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review94
In-person and virtual multidisciplinary intensive lifestyle interventions are equally effective in patients with type 2 diabetes and obesity57
Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults39
Effect of sodium-glucose cotransporter-2 inhibitors on patients with essential hypertension and pre-hypertension: a meta-analysis32
The global burden of thyroid cancer in high-income Asia-Pacific: a systematic analysis of the Global Burden of Disease study28
Controversies in the management of active Charcot neuroarthropathy26
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease22
Treatment of osteoporosis in the solid organ transplant recipient: an organ-based approach22
Glycaemic outcomes in people living with diabetes under 65 and over 65 years old using an intermittently scanned continuous glucose monitoring system20
Novel therapeutic targets for metabolism-related diseases: proteomic Mendelian randomization and colocalization analyses20
Differences in adherence to using removable cast walker treatment during daytime and nighttime weight-bearing activities in people with diabetes-related foot ulcers19
Is there a causal relationship between hypothyroidism and hyponatremia?18
Update on genetics and epigenetics in metabolic associated fatty liver disease18
Effectiveness of open-source Android artificial pancreas systems for glucose management in patients with type 1 diabetes: a real-world study17
Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor17
Pheochromocytoma: a changing perspective and current concepts17
0.034089088439941